Company / Tangible Book Value per Share
NEKTAR THERAPEUTICS Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$7.25
FY2025
5-year range
$0.68 / $7.25
FY2021-FY2025
Trend
+959.8%
vs FY2024
Sector context
#72 of 209
Health Care
What the data says
Tangible Book Value per Share changed +960% YoY in FY2025, a notable deviation from the 9-year average annual change of +1671%.
Based on SEC 10-K filings.
7.25 in FY2025 with a 5-year CAGR of -4.8%.
Improved from $1.54 to $7.25 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +66.8%
- 5-Year CAGR
- -4.8%
- 10-Year CAGR
- -
Sector benchmark
#72 of 209 in Health CareTop 34% of 209This company $7.25 Sector average $119.74
▼
-93.9% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 959.8% year-over-year.
- Ranks #72 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.25 | +959.8% |
| FY2024 | $0.68 | -55.5% |
| FY2023 | $1.54 | -1.6% |
| FY2022 | $1.56 | -53.3% |
| FY2021 | $3.35 | -64.0% |
| FY2020 | $9.30 | +14144.0% |
| FY2019 | $0.07 | -10.4% |
| FY2018 | $0.07 | -1.4% |
| FY2017 | $0.07 | +124.9% |
| FY2016 | -$0.30 | +44.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026